81 related articles for article (PubMed ID: 12774310)
1. Transplantation of human adult astrocytes: efficiency and safety requirements for an autologous gene therapy.
Ridet JL; Sarkis C; Serguera C; Zennou V; Charneau P; Mallet J
J Neurosci Res; 2003 Jun; 72(6):704-8. PubMed ID: 12774310
[TBL] [Abstract][Full Text] [Related]
2. Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes.
Selkirk SM; Greenberg SJ; Plunkett RJ; Barone TA; Lis A; Spence PO
Gene Ther; 2002 Apr; 9(7):432-43. PubMed ID: 11938458
[TBL] [Abstract][Full Text] [Related]
3. Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain.
Serguera C; Sarkis C; Ridet JL; Colin P; Moullier P; Mallet J
Mol Ther; 2001 Jun; 3(6):875-81. PubMed ID: 11407901
[TBL] [Abstract][Full Text] [Related]
4. Integration of genetically modified adult astrocytes into the lesioned rat spinal cord.
Pencalet P; Serguera C; Corti O; Privat A; Mallet J; Giménez y Ribotta M
J Neurosci Res; 2006 Jan; 83(1):61-7. PubMed ID: 16294335
[TBL] [Abstract][Full Text] [Related]
5. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes.
Ridet JL; Corti O; Pencalet P; Hanoun N; Hamon M; Philippon J; Mallet J
Hum Gene Ther; 1999 Jan; 10(2):271-80. PubMed ID: 10022551
[TBL] [Abstract][Full Text] [Related]
6. Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury.
Joosten EA; Veldhuis WB; Hamers FP
J Neurosci Res; 2004 Jul; 77(1):127-42. PubMed ID: 15197746
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.
Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN
J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931
[TBL] [Abstract][Full Text] [Related]
8. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
9. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo transduced liver progenitor cells as a platform for gene therapy in mice.
Song S; Witek RP; Lu Y; Choi YK; Zheng D; Jorgensen M; Li C; Flotte TR; Petersen BE
Hepatology; 2004 Oct; 40(4):918-24. PubMed ID: 15382177
[TBL] [Abstract][Full Text] [Related]
11. Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury.
Papastefanaki F; Chen J; Lavdas AA; Thomaidou D; Schachner M; Matsas R
Brain; 2007 Aug; 130(Pt 8):2159-74. PubMed ID: 17626035
[TBL] [Abstract][Full Text] [Related]
12. Lumbar transplantation of immortalized enkephalin-expressing astrocytes attenuates chronic neuropathic pain.
Xu Y; Tian XB; An K; Yang H; Tian YK
Eur J Pain; 2008 May; 12(4):525-33. PubMed ID: 17904399
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of human fetal neural stem/progenitor cells as a source for cell replacement therapy for neurological disorders: properties and tumorigenicity after long-term in vitro maintenance.
Ogawa D; Okada Y; Nakamura M; Kanemura Y; Okano HJ; Matsuzaki Y; Shimazaki T; Ito M; Ikeda E; Tamiya T; Nagao S; Okano H
J Neurosci Res; 2009 Feb; 87(2):307-17. PubMed ID: 18972448
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
15. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector.
Giannini C; Morosan S; Tralhao JG; Guidotti JE; Battaglia S; Mollier K; Hannoun L; Kremsdorf D; Gilgenkrantz H; Charneau P
Hepatology; 2003 Jul; 38(1):114-22. PubMed ID: 12829993
[TBL] [Abstract][Full Text] [Related]
16. Long-term fate of neural precursor cells following transplantation into developing and adult CNS.
Lepore AC; Neuhuber B; Connors TM; Han SS; Liu Y; Daniels MP; Rao MS; Fischer I
Neuroscience; 2006 May; 139(2):513-30. PubMed ID: 16458439
[TBL] [Abstract][Full Text] [Related]
17. Embryonic cerebral cortex cells retain CNS phenotypes after transplantation into peripheral nerve.
Baez JC; Gajavelli S; Thomas CK; Grumbles RM; Aparicio B; Byer D; Tsoulfas P
Exp Neurol; 2004 Oct; 189(2):422-5. PubMed ID: 15380492
[TBL] [Abstract][Full Text] [Related]
18. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum.
Darsalia V; Kallur T; Kokaia Z
Eur J Neurosci; 2007 Aug; 26(3):605-14. PubMed ID: 17686040
[TBL] [Abstract][Full Text] [Related]
19. First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells.
Chan J; Kumar S; Fisk NM
Hum Reprod; 2008 Nov; 23(11):2427-37. PubMed ID: 18687673
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
